PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.62%
Revenue growth at 50-75% of NXPI's 9.49%. Martin Whitman would worry about competitiveness or product relevance.
14.26%
Gross profit growth 1.25-1.5x NXPI's 10.77%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
51.57%
EBIT growth similar to NXPI's 47.83%. Walter Schloss might infer both firms share similar operational efficiencies.
129.37%
Operating income growth above 1.5x NXPI's 47.83%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
82.32%
Net income growth under 50% of NXPI's 892.86%. Michael Burry would suspect the firm is falling well behind a key competitor.
84.37%
EPS growth under 50% of NXPI's 884.31%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
81.25%
Diluted EPS growth under 50% of NXPI's 866.49%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.36%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.53%
Reduced diluted shares while NXPI is at 2.24%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
33.67%
Dividend growth of 33.67% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
87.22%
OCF growth above 1.5x NXPI's 34.45%. David Dodd would confirm a clear edge in underlying cash generation.
109.06%
FCF growth above 1.5x NXPI's 38.89%. David Dodd would verify if the firm’s strategic investments yield superior returns.
104.15%
10Y revenue/share CAGR above 1.5x NXPI's 13.53%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
8.82%
5Y revenue/share CAGR at 50-75% of NXPI's 13.53%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-4.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
179.43%
10Y OCF/share CAGR 1.25-1.5x NXPI's 139.56%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
55.41%
Below 50% of NXPI's 139.56%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.35%
3Y OCF/share CAGR under 50% of NXPI's 70.45%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
754.81%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
34.33%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
-6.00%
Negative 3Y CAGR while NXPI is 126.46%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
58.52%
Equity/share CAGR of 58.52% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
32.67%
Equity/share CAGR of 32.67% while NXPI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
24.26%
Below 50% of NXPI's 190.42%. Michael Burry suspects a serious short-term disadvantage in building book value.
1208.79%
Dividend/share CAGR of 1208.79% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
180.15%
Dividend/share CAGR of 180.15% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
130.21%
3Y dividend/share CAGR of 130.21% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
11.85%
AR growth well above NXPI's 6.25%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.18%
Inventory growth well above NXPI's 1.64%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.54%
Negative asset growth while NXPI invests at 0.24%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.43%
Under 50% of NXPI's 4.64%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-9.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-7.16%
Our R&D shrinks while NXPI invests at 1.31%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.61%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.